We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$468B
AUM Growth
-$6.98B
Cap. Flow
+$2.33B
Cap. Flow %
0.5%
Top 10 Hldgs %
16.09%
Holding
2,594
New
78
Increased
1,210
Reduced
770
Closed
91

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$1.36B
2
PM icon
Philip Morris
PM
+$1.3B
3
AMZN icon
Amazon
AMZN
+$1.21B
4
SYK icon
Stryker
SYK
+$1.12B
5
AET
Aetna Inc
AET
+$1.08B

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.46B
2
GILD icon
Gilead Sciences
GILD
+$1.1B
3
DIS icon
Walt Disney
DIS
+$866M
4
AKAM icon
Akamai
AKAM
+$703M
5
CMG icon
Chipotle Mexican Grill
CMG
+$647M

Sector Composition

Rank Sector Weight
1 Healthcare 20.69%
2 Consumer Discretionary 15.01%
3 Financials 13.64%
4 Technology 12.55%
5 Industrials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGY
2576
DELISTED
Stone Energy
SGY
-1,197
Closed -$292K
REXX
2577
DELISTED
Rex Energy Corporation
REXX
-3,720
Closed -$39K
OREX
2578
DELISTED
Orexigen Therapeutics, Inc.
OREX
-650,842
Closed -$11.2M
CB
2579
DELISTED
CHUBB CORPORATION
CB
-3,740,821
Closed -$496M
POM
2580
DELISTED
PEPCO HOLDINGS, INC.
POM
-467,800
Closed -$12.2M

Similar funds

T. Rowe Price Associates's Q1 2016 Portfolio in Review

As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
  • T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
  • T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
  • T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
  • T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
  • T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.

Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.